Virginia Haurigot
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 23, 2026
Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responses.
Journal: Frontiers in immunology
Published: January 29, 2026
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage.
AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal.
Journal: Molecular therapy. Methods & clinical development
Published: March 16, 2021
In Vivo Gene Therapy for Mucopolysaccharidosis Type III (Sanfilippo Syndrome): A New Treatment Horizon.
Journal: Human gene therapy
Published: September 05, 2019
FGF21 gene therapy as treatment for obesity and insulin resistance.
Journal: EMBO molecular medicine
Published: July 11, 2018
Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.
Journal: Molecular therapy. Methods & clinical development
Published: March 22, 2017
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.
Journal: Molecular metabolism
Published: March 17, 2017
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
Journal: Human molecular genetics
Published: December 02, 2016
Last Updated: 09/26/2026